Humedix Co., Ltd. (KOSDAQ:200670)

South Korea · Delayed Price · Currency is KRW

24,600

-1,550 (-5.93%)

Jul 20, 2026, 3:30 PM KST

-57.07% (1Y)

Market Cap	269.87B -52.9%
Revenue (ttm)	110.99B +12.7%
Net Income	9.06B -39.9%
EPS	963.99 -39.3%
Shares Out	10.32M
PE Ratio	27.13
Forward PE	6.21
Dividend	660.00 (2.52%)
Ex-Dividend Date	May 26, 2026

Volume	34,094
Open	25,800
Previous Close	26,150
Day's Range	24,600 - 25,850
52-Week Range	23,800 - 77,200
Beta	0.34
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 12, 2026

About Humedix

Humedix Co., Ltd. engages in the manufacture and sale of various pharmaceutical products in South Korea. The company offers prescription medicines, active pharmaceutical ingredients, medical devices, cosmetics, and health functional food products. It is also involved in the manufacture and distribution of anticancer drugs. The company was formerly known as HVLS Co., Ltd. and changed its name to Humedix Co., Ltd. in 2010. Humedix Co., Ltd. was founded in 2002 and is headquartered in Seongnam-si, South Korea. [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2002

Employees 248

Stock Exchange KOSDAQ

Ticker Symbol 200670

Full Company Profile

Financial Performance

In 2021, Humedix's revenue was 110.99 billion, an increase of 12.70% compared to the previous year's 98.48 billion. Earnings were 9.06 billion, a decrease of -39.91%.

Financial Statements